Choosing ibrutinib wisely

Blood. 2018 Jan 11;131(2):156-157. doi: 10.1182/blood-2017-11-813907.

Abstract

In this issue of Blood, Bartlett et al share their experience with the use of ibrutinib in patients with relapsed or refractory follicular lymphoma (FL).

Publication types

  • Comment

MeSH terms

  • Adenine / analogs & derivatives
  • Humans
  • Lymphoma, Follicular*
  • Piperidines
  • Practice Patterns, Physicians'
  • Pyrazoles
  • Pyrimidines

Substances

  • Piperidines
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Adenine